Recent Progress in Benzothiazole-based Molecules for Cognitive Dysfunction
Current treatment of cognitive dysfunction is limited and a significant challenge in therapy due to the limited efficacy of available acetylcholinesterase inhibitors (AChEIs) and their side effects. Therefore, in medicinal chemistry, the search for safer, selective, and multitarget-directed therapeutic agents has attracted much attention. Benzothiazole is one of the most promising heterocyclic frameworks, particularly because it is highly bioisosteric, has a promising pharmacokinetic profile, and has high neuroprotective properties. The special structural characteristics of the benzothiazole nucleus enable interactions with a wide variety of biological targets associated with memory impairments and neurodegenerative disorders. Based on the structure of the known drug, a series of novel benzothiazole-based derivatives was rationally designed as potential anti-amnesic agents in the present study. The therapeutic significance of the benzothiazole functional group in the discovery of novel candidates for the management of cognitive dysfunction and memory-related disorders was highlighted.
Authors
- Lakshmi rajput
- Anuradha Sharma (ORCID: https://orcid.org/0000-0002-3835-394X)
Publication Details
- Journal
- Current Journal of Life Sciences
- Published
- 2026-11-12
- DOI
- https://doi.org/10.2174/01305077157073261102203409
- Primary Topic
- Cholinesterase and Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00